[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today

Bristol-Myers Squibb (BMY) shares opened higher on Monday following reports that the U.S. pharma giant held preliminary merger talks with UK rival AstraZeneca (AZN). If finalized, this reported transaction would create the world’s largest drugmaker (by revenue) with a market cap approaching $400 billion. 

The AstraZeneca rumors arrive at a time when Bristol-Myers stock is already in a massive uptrend, currently up more than 20% versus its low in mid-June. 

Fundamentals

See More
  • Market Capitalization, $K 133,367,648
  • Shares Outstanding, K 2,042,071
  • Annual Sales, $ 48,194 M
  • Annual Income, $ 7,054 M
  • EBIT $ 12,521 M
  • EBITDA $ 16,532 M
  • 60-Month Beta 0.23
  • Price/Sales 2.75
  • Price/Cash Flow 7.98
  • Price/Book 6.59

Options Overview Details

View History
  • Implied Volatility 31.49% (+1.62%)
  • Historical Volatility 28.87%
  • IV Percentile 69%
  • IV Rank 53.84%
  • IV High 40.88% on 11/19/25
  • IV Low 20.52% on 12/31/25
  • Expected Move (DTE 3) 1.84 (2.80%)
  • Put/Call Vol Ratio 1.04
  • Today's Volume 68,371
  • Volume Avg (30-Day) 31,449
  • Put/Call OI Ratio 0.92
  • Today's Open Interest 711,174
  • Open Int (30-Day) 625,763
  • Expected Range 63.63 to 67.31

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $1.66
  • Number of Estimates 9
  • High Estimate $1.74
  • Low Estimate $1.59
  • Prior Year $1.63
  • Growth Rate Est. (year over year) +1.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.49 +15.90%
on 07/06/26
68.10 -3.86%
on 08/03/26
+7.34 (+12.63%)
since 07/02/26
3-Month
53.44 +22.51%
on 06/18/26
68.10 -3.86%
on 08/03/26
+7.25 (+12.45%)
since 05/01/26
52-Week
42.52 +53.97%
on 10/29/25
68.10 -3.86%
on 08/03/26
+21.24 (+48.02%)
since 08/01/25

Most Recent Stories

More News
The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today

Bristol-Myers stock extends gains on reports of a potential merger with AstraZeneca. But caution is warranted in chasing the momentum in BMY shares today.

AZN : 157.97 (-6.88%)
BMY : 65.47 (+0.24%)
Stocks Set to Open Higher as Oil Sinks on U.S.-Iran Deal Hopes, Jobs Data and Earnings Awaited

September S&P 500 E-Mini futures (ESU26) are up +0.57%, and September Nasdaq 100 E-Mini futures (NQU26) are up +0.47% this morning, pointing to a higher open on Wall Street as oil prices sank after U.S....

GOOGL : 373.51 (+4.88%)
UAL : 128.39 (+5.82%)
AAPL : 303.42 (-1.78%)
SNDK : 1,288.03 (+6.03%)
NQU26 : 29,077.25 (+0.64%)
PFE : 25.03 (+0.08%)
SHOP : 117.01 (-0.12%)
MSFT : 487.65 (+4.93%)
TSLA : 322.08 (+3.49%)
FERG : 250.08 (+6.72%)
WDC : 527.22 (-3.23%)
ESU26 : 7,637.75 (+0.12%)
BMY Q2 Deep Dive: Growth Portfolio and Pipeline Progress Drive Upgraded Outlook

BMY Q2 Deep Dive: Growth Portfolio and Pipeline Progress Drive Upgraded Outlook

BMY : 65.47 (+0.24%)
Bristol-Myers Squibb (NYSE:BMY) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales

Bristol-Myers Squibb (NYSE:BMY) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales

BMY : 65.47 (+0.24%)
Bristol Myers Squibb Reports Second Quarter Financial Results for 2026

Bristol Myers Squibb (NYSE: BMY) today reported second quarter 2026 financial results. Visit the company’s Investor Relations website at http://investor.bms.com ...

BMY : 65.47 (+0.24%)
Bristol-Myers Squibb: Wall Street's Bearish Revisions May Have Overcorrected This Time

Barchart Research What to Expect from BMY Earnings BMY Generated July 29, 2026 Current Price $63.10 EPS Estimate $$1.59 Consensus Rating Moderate Buy Average Move 5.36% Bristol-Myers Squibb: Wall Street's...

BMY : 65.47 (+0.24%)
Bristol-Myers Squibb Stock: Analyst Estimates & Ratings

Bristol-Myers Squibb has rallied the broader market over the past year, and analysts remain moderately bullish about the stock’s prospects.

XLV : 162.24 (-0.19%)
$SPX : 7,600.50 (+1.48%)
BMY : 65.47 (+0.24%)
Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q2 Results Tomorrow

Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q2 Results Tomorrow

BMY : 65.47 (+0.24%)
Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now

As investors rotate toward value, Altria, Bristol Myers Squibb, and American Electric Power stand out as reliable dividend stocks with strong payout growth histories and defensive appeal.

MO : 68.26 (-0.10%)
AEP : 128.32 (+0.37%)
BMY : 65.47 (+0.24%)
3 Healthcare Stocks We Keep Off Our Radar

3 Healthcare Stocks We Keep Off Our Radar

CHE : 540.57 (+1.56%)
VTRS : 17.63 (+0.40%)
BMY : 65.47 (+0.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers...

See More

Key Turning Points

3rd Resistance Point 71.63
2nd Resistance Point 69.86
1st Resistance Point 67.67
Last Price 65.47
1st Support Level 63.71
2nd Support Level 61.94
3rd Support Level 59.75

See More

52-Week High 68.10
Last Price 65.47
Fibonacci 61.8% 58.33
Fibonacci 50% 55.31
Fibonacci 38.2% 52.29
52-Week Low 42.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.